IP Library Granted Patent US 10,722,389
Granted Patent B2
US 10,722,389 · App. 15/542,072 · Granted Jul 28, 2020

Endoluminal stent

Inventors: Sunil Pundlikrao Kale (Gujarat, IN); Bhautikkumar Chandulal Khanpara (Gujarat, IN)
Assignee: SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED
A61F2/915A61F2002/91533A61F2002/91583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,389
App. No.
15/542,072
Granted
Jul 28, 2020
Kind
B2
Abstract

An endoluminal stent ( 100 ) is described herein. In an embodiment, the endoluminal stent ( 100 ) includes a plurality of sinusoidal-shaped expandable ringlets ( 102 ) provided in parallel to form a tubular structure of the endoluminal stent ( 100 ). Further, adjacent ringlets ( 102 ) can be connected to each other by one or more asymmetrical offset connectors ( 108 ), the offset connectors ( 108 ) being non-linear in structure.

Claims (12)

1. An endoluminal stent comprising:

a plurality of ringlets forming a lateral surface of the endoluminal stent, each of the plurality of ringlets having a sinusoidal structure along a length of the ringlet, wherein the sinusoidal structure is formed as contained in a cylindrical plane of the lateral surface of the endoluminal stent, wherein the plurality of ringlets are coaxial to each other and are provided along a central longitudinal axis; and

a plurality of connectors to couple adjacent ringlets, wherein one end of each corresponding connector of the plurality of connectors is coupled to one ringlet at a first junction and another end of the corresponding connector is coupled to an adjacent ringlet at a second junction, wherein an axis passing through the first junction and parallel to the central longitudinal axis is at an offset with respect to another axis passing through the second junction and parallel to the central longitudinal axis, wherein each of the plurality of connectors is of sinusoidal structure and at least one radius in the sinusoidal structure, being measured at a point at least halfway to a midpoint of a corresponding connector, is in a range of 0.4 mm to 0.7 mm,

wherein, for each corresponding connector, the first junction is located at a mid-portion of a connecting element that connects ends of two crown peaks that are oriented in opposite directions in the one ringlet and the second junction is located at a mid-portion of another connecting element that connects ends of two crown peaks that are oriented in opposite directions in the adjacent ringlet.

2. The endoluminal stent as claimed in claim 1 , wherein each of the plurality of ringlets comprise:

a plurality of arc-shaped first crowns; and

a plurality of arc-shaped second crowns, each of the plurality of arc-shaped first crowns and the arc-shaped second crowns having a first end and a second end and an orientation of the plurality of arc-shaped first crowns being opposite to the orientation of the plurality of arc-shaped second crowns.

3. The endoluminal stent as claimed in claim 1 , wherein the plurality of ringlets is made of a metal, a metal alloy, a biodegradable polymer, a biostable polymer, and any combination thereof.

4. The endoluminal stent as claimed in claim 1 , wherein the plurality of connectors are flexible.

5. The endoluminal stent as claimed in claim 1 , wherein material for making ringlets is selected from, but not limited to Stainless steel, Tantalum, Niobium, Magnesium alloys, Zinc alloys, L605, MP25N, Nitinol or a combination of thereof.

6. The endoluminal stent as claimed in claim 1 , wherein material for making ringlets is selected from, but not limited to L-lactide, Glycolide or combinations of thereof, poly(hydroxybutyrate), polyorthoesters, poly anhydrides, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D-lactic acid), poly(D-lactide), poly(caprolactone), poly(trimethylene carbonate), polyester amide, polyesters, polyolefins, polycarbonates, polyoxymethylenes, polyimides, polyethers, and copolymers and combinations thereof.

7. The endoluminal stent as claimed in claim 1 , has a coating selected from a biodegradable polymer coating, a biostable polymer coating, a passive coating, a therapeutic agent coating or a combination of thereof.

Assignments (3)
CHANGE OF NAME Recorded Jan 8, 2025
From: SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED
To: SAHAJANAND MEDICAL TECHNOLOGIES LIMITED
Reel/Frame 069842/0792 →
CHANGE OF NAME Recorded Aug 10, 2021
From: SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED
To: SAHAJANAND MEDICAL TECHNOLOGIES LIMITED
Reel/Frame 057142/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2017
From: KALE, SUNIL PUNDLIKRAO; KHANPARA, BHAUTIKKUMAR CHANDULAL
To: SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED
Reel/Frame 043010/0820 →
Priority Claims (1)
IN 65/MUM/2015 · Jan 7, 2015 · national
Continuity (1)
Related Publication 20180000618A1 · Jan 4, 2018